# Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia

> **NCT05315011** · NA · SUSPENDED · sponsor: **University Hospital, Montpellier** · enrollment: 70 (estimated)

## Conditions studied

- Breast Cancer
- Aromatase Inhibitors

## Interventions

- **OTHER:** Whole-body cryotherapy
- **OTHER:** Placebo cryotherapy

## Key facts

- **NCT ID:** NCT05315011
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-05-05
- **Primary completion:** 2026-05-04
- **Final completion:** 2027-05-04
- **Target enrollment:** 70 (ESTIMATED)
- **Why stopped:** The cryotherapy center has closed due to liquidation.
- **Last updated:** 2025-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05315011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05315011, "Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05315011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*